Telix Pharmaceuticals (ASX:TLX) received notice that its Chief Executive Christian Behrenbruch sold 2 million shares in the company at AU$29.50 per share by way of a block trade, according to a Thursday Australian bourse filing.
Behrenbruch now holds shares equal to about 6.3% of the company's issued capital and has no intention to sell them, the filing said.
Additionally, the company's co-founder Andreas Kluge sold 2 million shares in the company for the same price.
Company shares were down nearly 2% in recent Thursday trade.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。